---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-290823"
form_type: "8-K"
ticker: "NUVB"
cik: "0001811063"
company_name: "Nuvation Bio Inc."
filed_at: "2026-06-30T21:17:05+00:00"
generated_at: "2026-06-30T21:18:08.147533+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Nuvation Bio closes $250M 0.75% convertible senior notes offering due 2032

## Summary
- $250M aggregate principal of 0.75% Convertible Senior Notes due 2032; initial conversion price ~$7.84/share (35% premium).
- Net proceeds ~$241.2M; used to repay $58.5M loan, pay $14.9M for capped call, remainder for general corporate.
- Capped call transactions entered to reduce dilution; cap price $10.4580/share (80% premium).
- Underwriters' 30-day option for additional $37.5M notes.
- Prior loan agreement terminated upon full repayment of ~$58.5M.

## SEC filing metadata
- accession: 0001193125-26-290823
- form_type: 8-K
- ticker: NUVB
- cik: 0001811063
- company_name: Nuvation Bio Inc.
- filed_at: 2026-06-30T21:17:05+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 8.01, 1.02, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1811063/000119312526290823/0001193125-26-290823-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1811063/000119312526290823/d81296d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-290823
- JSON: https://secwatch.observer/filing/0001193125-26-290823.json
- Plain text: https://secwatch.observer/filing/0001193125-26-290823.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.